February 2025 - Page 108 of 121

Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20

February 5, 2025

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology...

Johnson Controls Reports Strong Q1 Results; Raises FY25 Guidance

February 5, 2025

Q1 sales increased 4% and organic sales increased 10%* Q1 GAAP EPS of $0.55; Q1 Adjusted EPS* of $0.64 Q1...

FirstService Reports Fourth Quarter and Full Year Results

February 5, 2025

Operating highlights: Three months ended Year ended December 31 December 31 2024 2023 2024 2023 Revenues (millions)$1,365.3 $1,079.3 $5,216.9 $4,334.5Adjusted EBITDA (millions) (note 1) 137.9 103.3 513.7 415.7Adjusted EPS (note 2) 1.34 1.11 5.00 4.66 GAAP Operating Earnings 89.6 48.1 337.5 244.9GAAP EPS 0.71 0.14 2.97 2.24 TORONTO,...

Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device

February 5, 2025

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company...

AZZ Inc. Issues Fiscal Year 2026 Guidance

February 5, 2025

FORT WORTH, Texas, Feb. 5, 2025 /PRNewswire/ -- AZZ Inc. (NYSE: AZZ), the leading independent provider of hot-dip galvanizing and coil...

T2 Metals Reports High Grade Copper in Drill Results at the Sherridon VMS Project, Manitoba

February 5, 2025

Vancouver, British Columbia--(Newsfile Corp. - February 5, 2025) - T2 Metals Corp. (TSXV: TWO) (OTCQB: TWOSF) (WKN: A2DR6E) ("T2" or...

Bio-Techne Releases Second Quarter Fiscal 2025 Results

February 5, 2025

MINNEAPOLIS, Feb. 5, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ending...

Aurora Cannabis Announces Fiscal 2025 Third Quarter Results

February 5, 2025

NASDAQ | TSX: ACB Reports Total Net Revenue1 of $88.2 Million, up 37% YoY, Including Record Net Revenue1 of $68.1...

Breaking News: MoBot’s Latest Update as of 02/05/25 08:00 AM

February 5, 2025

DENVER, Colo., 02/05/25 08:00 AM (247marketnews.com) – (NASDAQ: ACB, NASDAQ: CPIX, NASDAQ: ACET, NASDAQ: CYN, NASDAQ: KTTA) are discussed in...

Spire reports FY25 first quarter results

February 5, 2025

ST. LOUIS, Feb. 5, 2025 /PRNewswire/ -- Spire Inc. (NYSE: SR) today reported results for its fiscal 2025 first quarter...

Rhythm Pharmaceuticals to Present at Oppenheimer Annual Healthcare Life Sciences Conference in February

February 5, 2025

BOSTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the...

FDA Grants Adicet Bio’s ADI-001 Fast Track Designation for SLE Treatment

February 5, 2025

DENVER, Colo., Feb 05, 2025 (247marketnews.com)- Adicet Bio (NASDAQ:ACET) stated that the U.S. Food and Drug Administration (FDA) granted Fast...

Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Participate in the 12th Annual Brain Health Summit at the Leigh Steinberg Super Bowl Party 2025

February 5, 2025

SARASOTA, Fla., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for...

24/7 Market News Snapshot 05 February, 2025 – Aurora Cannabis Inc. Common Shares (NASDAQ:ACB)

February 5, 2025

DENVER, Colo., 05 February, 2025 (247marketnews.com) – (NASDAQ:ACB) are discussed in this article. Aurora Cannabis Inc. is currently experiencing a...

Kennametal Announces Fiscal 2025 Second Quarter Results

February 5, 2025

Strong YTD cash from operations of $101 million compared to $88 million in the prior year; free operating cash flow...

24/7 Market News Snapshot 05 February, 2025 – Oragenics Inc. (NYSE:OGEN)

February 5, 2025

DENVER, Colo., 05 February, 2025 (247marketnews.com) – (NYSE:OGEN) are discussed in this article. Oragenics Inc. is experiencing a remarkable surge...

RETRANSMISSION: Manganese X Energy Corp. Reports Key Achievements and Outlines 2025 Strategies

February 5, 2025

Montreal, Quebec--(Newsfile Corp. - February 5, 2025) - Manganese X Energy Corp. (TSXV: MN) (FSE: 9SC) (TRADEGATE: 9SC) (OTCQB: MNXXF)...

Recent Draganfly Sales and Activities with Policing Agencies Signals Growing Focus on Northern (Canada) Border Security

February 5, 2025

Draganfly Confirms Its Strategic & Tactical Positioning and Preparedness for Growing Border Security Demand Amid Global Trade and Security Initiatives...

DeFi Technologies Provides Monthly Corporate Update: Valour Reports C$1.4 Billion (US$1.009 Billion) in AUM, and Monthly Net Inflows of C$48 Million (US$33.5 Million) in January 2025, Along with a Treasury Strategy Update

February 5, 2025

AUM & Robust Monthly Net Inflows: As of January 31, 2024, Valour reported C$1.4 billion (US$1.009 Billion) in assets under...

Dayforce Reports Fourth Quarter and Full Year 2024 Results1

February 5, 2025

Dayforce® recurring revenue of $347.9 million, up 19% year-over-year in the fourth quarter Total revenue of $465.2 million, up 16%...

C3 Metals Geochemical Program Confirms +5km Gold Trend on the Super Block Project, Jamaica

February 5, 2025

Toronto, Ontario--(Newsfile Corp. - February 5, 2025) - C3 Metals Inc. (TSXV: CCCM) (OTCQB: CUAUF) ("C3 Metals" or the "Company")...

Costamare Inc. Reports Results for the Fourth Quarter and Year Ended December 31, 2024

February 5, 2025

MONACO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Costamare Inc. (“Costamare” or the “Company”) (NYSE: CMRE) today reported unaudited financial results...

Pasithea Therapeutics Receives Positive SRC Recommendation for its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer

February 5, 2025

DENVER, Colo., Feb 05, 2025 (247marketnews.com)- Pasithea Therapeutics (NASDAQ:KTTA) reported that its Phase 1 clinical trial of PAS-004 in advanced...

Perspective Therapeutics to Participate in Upcoming February Investor Conferences

February 5, 2025

SEATTLE, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company...

Bayridge Resources Confirms Multiple Targets at Constellation Project

February 5, 2025

Vancouver, British Columbia--(Newsfile Corp. - February 5, 2025) - Bayridge Resources Corp. (CSE: BYRG) (OTCQB: BYRRF) (FSE: O0K) ("Bayridge" or...

BioXcel Therapeutics Provides Clinical and Business Update

February 5, 2025

Patient enrollment advancing in SERENITY At-Home Phase 3 trial of BXCL501 for acute treatment of agitation associated with bipolar disorders...

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

February 5, 2025

- Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function-...

Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Refractory Systemic Lupus Erythematosus (SLE) with Extrarenal Involvement

February 5, 2025

REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma...

Don’t Miss Out: MoBot’s Latest Stock Updates 02/05/25 07:00 AM

February 5, 2025

DENVER, Colo., 02/05/25 07:00 AM (247marketnews.com) – (NASDAQ: ACET, NASDAQ: CYN, NASDAQ: KTTA, NASDAQ: ASST, NASDAQ: UPC) are discussed in...

Theravance Biopharma to Participate in an Upcoming Investor Conference

February 5, 2025

DUBLIN, Feb. 5, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will present at the Oppenheimer 35th Annual Healthcare Life...

Power Nickel Hole PN-24-095a Delivers 10.60% CuEq1 over 5.35 Metres Within 3.61% CuEq1 over 19.40 Metres

February 5, 2025

TORONTO, Feb. 5, 2025 /PRNewswire/ - Power Nickel Inc. (the "Company" or "Power Nickel") (TSXV: PNPN) (OTCBB: PNPNF) (Frankfurt: IVV) is pleased to announce the...

Medicenna Therapeutics to Participate in Two Healthcare Investor Conferences in February 2025

February 5, 2025

TORONTO and HOUSTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage...

Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer

February 5, 2025

SRC recommended that the trial escalate to the next dose level of 22mg capsuleNo dose-limiting toxicities (DLT’s) or rash observed...

SunHydrogen Achieves Highest Known Efficiency for a Large-Area Hydrogen Module

February 5, 2025

CORALVILLE, IA , Feb. 05, 2025 (GLOBE NEWSWIRE) -- SunHydrogen, Inc. (OTCQB: HYSR), the developer of a breakthrough technology to...

24/7 Market News Snapshot 05 February, 2025 – Adicet Bio, Inc. Common Stock (NASDAQ:ACET)

February 5, 2025

DENVER, Colo., 05 February, 2025 (247marketnews.com) – (NASDAQ:ACET) are discussed in this article. Adicet Bio, Inc. (NASDAQ: ACET) is experiencing...

24/7 Market News Snapshot 05 February, 2025 – Pasithea Therapeutics Corp. Common Stock (NASDAQ:KTTA)

February 5, 2025

DENVER, Colo., 05 February, 2025 (247marketnews.com) – (NASDAQ:KTTA) are discussed in this article. Pasithea Therapeutics Corp. is experiencing a significant...